Loading clinical trials...
Loading clinical trials...
This study aims to determine whether dysbiosis actively contributes to HNSCC and if so, the underlying molecular mechanisms.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Colorado, Denver
Collaborators
NCT05076760 · Solid Tumor, Advanced Cancer, and more
NCT06851663 · Solid Tumor, Solid Carcinoma, and more
NCT06682494 · Oral Cancer, Chatbot, and more
NCT07124000 · Adenocarcinoma (NOS), Anal Cancer, and more
NCT07209189 · Head and Neck Cancer, Squamous Cell Carcinoma, and more
University of Colorado Cancer Center
Aurora, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions